| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |